New Research Uncovers Gut Microbe-Derived Metabolites as Potential Therapy for Obesity-Related Metabolic Disorders
This link is to an interview from my previous supervisor on our work detailed in our publication: Gut Microbial Metabolites of Tryptophan Augment Enteroendocrine Cell Differentiation in Human Colonic Organoids: Therapeutic Potential for Dysregulated GLP1 Secretion in Obesity